Home/Pipeline/Pegfilgrastim Biosimilar

Pegfilgrastim Biosimilar

Neutropenia

ApprovedCommercial

Key Facts

Indication
Neutropenia
Phase
Approved
Status
Commercial
Companies

About Dr. Reddy's Laboratories

Dr. Reddy's Laboratories is a vertically integrated pharmaceutical company with capabilities spanning drug discovery, development, manufacturing, and commercialization. The company has built a strong portfolio of generic drugs, particularly in the US market, while also investing in complex generics, biosimilars, and proprietary drug development. With manufacturing facilities across multiple countries and a global workforce, Dr. Reddy's continues to expand its market presence through strategic partnerships, acquisitions, and new product launches. The company is publicly traded on both Indian stock exchanges and NASDAQ, reflecting its status as a major player in the global pharmaceutical industry.

View full company profile

About Alembic Pharmaceuticals

Alembic Pharmaceuticals is a vertically integrated, publicly listed Indian pharmaceutical company with a century-long legacy. It operates through two main segments: Generics and Branded Generics, with a robust manufacturing infrastructure and a growing international footprint, particularly in the US market. The company is strategically focused on complex generics, biosimilars, and specialty products to drive future growth, supported by significant R&D investments.

View full company profile

About Strides Pharma

Strides Pharma is a global pharmaceutical company headquartered in Bengaluru, India, with a core mission to provide affordable, high-quality generic medicines worldwide. The company has established itself as a leader in niche and complex therapeutic segments, including anti-retrovirals, anti-malarials, and softgel technologies, with a significant footprint in the US, Africa, Asia, and other regulated markets. Its strategic direction involves expanding its portfolio of complex generics, biosimilars, and specialty products while leveraging its robust manufacturing and R&D capabilities. Key achievements include a successful IPO, strategic acquisitions, and a consistent track record of ANDA filings and approvals in the US market.

View full company profile

Other Neutropenia Drugs

DrugCompanyPhase
Fulphila (Pegfilgrastim)BioconApproved